MannKind Corp (MNKD)
4.62
+0.15
(+3.36%)
USD |
NASDAQ |
Mar 18, 16:00
4.66
+0.04
(+0.87%)
After-Hours: 20:00
MannKind Profit Margin (Quarterly): 2.40% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.40% |
September 30, 2023 | 3.36% |
June 30, 2023 | -10.83% |
March 31, 2023 | -24.11% |
December 31, 2022 | -49.77% |
September 30, 2022 | -43.97% |
June 30, 2022 | -153.6% |
March 31, 2022 | -216.8% |
December 31, 2021 | -224.2% |
September 30, 2021 | -19.93% |
June 30, 2021 | -152.6% |
March 31, 2021 | -74.08% |
December 31, 2020 | -143.2% |
September 30, 2020 | -73.31% |
June 30, 2020 | -67.83% |
March 31, 2020 | -57.42% |
December 31, 2019 | -89.18% |
September 30, 2019 | -71.05% |
June 30, 2019 | -82.57% |
March 31, 2019 | -85.30% |
December 31, 2018 | -60.82% |
September 30, 2018 | -540.8% |
June 30, 2018 | -582.5% |
March 31, 2018 | -876.9% |
December 31, 2017 | -723.7% |
Date | Value |
---|---|
September 30, 2017 | -1.61K% |
June 30, 2017 | -1.63K% |
March 31, 2017 | -542.5% |
December 31, 2016 | |
September 30, 2016 | 77.93% |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | -122.4K% |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-224.2%
Minimum
Dec 2021
3.36%
Maximum
Sep 2023
-81.70%
Average
-72.18%
Median
Profit Margin (Quarterly) Benchmarks
United Therapeutics Corp | 35.32% |
Corcept Therapeutics Inc | 23.16% |
Cassava Sciences Inc | -- |
Amphastar Pharmaceuticals Inc | 20.31% |
Cogent Biosciences Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -3.51% |
Return on Invested Capital | -60.02% |
Gross Profit Margin (Quarterly) | 69.10% |
Operating Margin (Quarterly) | 18.19% |
Return on Net Operating Assets | -10.37% |